Cargando…
Novel Discoveries Targeting Pathogenic Gut Microbes and New Therapies in Pancreatic Cancer: Does Pathogenic E. coli Infection Cause Pancreatic Cancer Progression Modulated by TUBB/Rho/ROCK Signaling Pathway? A Bioinformatic Analysis
Pancreatic cancer (PC) is a pernicious cancer of the digestive system which remains a high degree of malignancy. Increasing studies demonstrated that regulating the gut microbiome may become a brand new strategy to improve the therapeutic outcomes of PC. This study is aimed at obtaining the pathway...
Autores principales: | Luo, Wenhao, Cao, Zhe, Qiu, Jiangdong, Liu, Yueze, Zheng, Lianfang, Zhang, Taiping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238364/ https://www.ncbi.nlm.nih.gov/pubmed/32461969 http://dx.doi.org/10.1155/2020/2340124 |
Ejemplares similares
-
Is Invagination Anastomosis More Effective in Reducing Clinically Relevant Pancreatic Fistula for Soft Pancreas After Pancreaticoduodenectomy Under Novel Fistula Criteria: A Systematic Review and Meta-Analysis
por: Cao, Zhe, et al.
Publicado: (2020) -
Novel discoveries targeting gemcitabine‐based chemoresistance and new therapies in pancreatic cancer: How far are we from the destination?
por: Luo, Wenhao, et al.
Publicado: (2019) -
Novel therapies targeting hypoxia mechanism to treat pancreatic cancer
por: Luo, Wenhao, et al.
Publicado: (2021) -
Novel therapeutic strategies and perspectives for metastatic pancreatic cancer: vaccine therapy is more than just a theory
por: Luo, Wenhao, et al.
Publicado: (2020) -
The Role of Mitochondria in the Chemoresistance of Pancreatic Cancer Cells
por: Fu, Yibo, et al.
Publicado: (2021)